CIGNA Category III CPT Code Policy Update: What Billing Teams Need to Know Before March 2026

CIGNA has issued a modified coverage position for Category III Current Procedural Terminology (CPT) codes under its internal policy tracking designation MM_0558. Set to take effect March 15, 2026, this update signals that Cigna Healthcare is revisiting how it evaluates emerging technology procedures billed under Category III codes—a category that already carries significant scrutiny in the revenue cycle world. If your practice bills Category III codes to CIGNA, this future-effective policy warrants immediate attention.

What Are Category III CPT Codes and Why Does CIGNA's Policy Matter?

Category III CPT codes are four-digit codes with a trailing "T" that the American Medical Association (AMA) assigns to emerging, experimental, or newly developed medical technologies and services. Unlike Category I CPT codes—which represent established procedures with documented clinical utility—Category III codes are placeholders that allow data collection on procedures that haven't yet earned full AMA recognition.

From a payer policy standpoint, Category III codes are some of the most contested codes in billing. Most payers, including CIGNA, default to treating many of them as experimental or investigational (E&I), which means they're excluded from coverage under most commercial benefit plans. The critical word is "many"—not all. A subset of Category III codes does meet CIGNA's medical necessity criteria under specific clinical circumstances, and that distinction is exactly what MM_0558 governs.

When CIGNA modifies this policy, it can mean newly covered codes, newly excluded codes, updated prior authorization requirements, or tightened medical necessity criteria for codes that were previously covered without restriction. Because the policy touches the entire Category III code set, the breadth of potential impact across specialties is wide.

What Changed in CIGNA MM_0558 — Category III CPT Policy

The MM_0558 policy modification is classified as a future-effective change with an implementation date of March 15, 2026. While Cigna Healthcare has not published granular line-by-line criteria in the summary available at time of publication, several things are clear from the policy's structure and history:

This is a modified—not new—policy. MM_0558 has existed as part of CIGNA's Coverage Position Criteria framework, which means this update represents a revision to existing language rather than a policy created from scratch. For billing teams, that distinction matters: you should be comparing the new version against the prior version to identify exactly what shifted.

Category III policies are inherently high-stakes. Procedures billed under Category III codes already face elevated denial risk because of their experimental/investigational classification baseline. Any modification to CIGNA's criteria for these codes—even a narrowing of which diagnoses qualify, or a new prior authorization requirement—can trigger a wave of denials if your team doesn't adapt before the effective date.

The "future effective" designation gives you a runway. CIGNA has signaled this change in advance of the March 2026 date. That's a gift in revenue cycle management—use it. Teams that wait until mid-March to review their workflows will face retroactive denial issues that are significantly harder to appeal than proactive adjustments.

Affected Codes

The full MM_0558 policy document governs CIGNA's coverage position for Category III CPT codes broadly. The specific version of this policy available at time of publication does not include a detailed code-level table in the data provided to this analysis.

What this means for your team: Do not assume the absence of a code list here means the policy doesn't affect you. CIGNA's Category III policy typically spans dozens of codes across procedure types. The most accurate and current code-level detail—including which codes are covered when selection criteria are met, and which are classified as experimental/investigational—is available in the full policy document.

Access the full policy here: CIGNA MM_0558 Coverage Position Criteria — Category III CPT Codes

For billing teams conducting their own analysis, the general framework CIGNA uses for Category III codes typically includes three tiers:

Understanding which tier applies to each code your practice bills is the foundation of your pre-March 2026 preparation.

Prior Authorization Considerations for CIGNA Category III Claims

Prior authorization requirements for Category III codes are some of the most variable in payer policy. CIGNA's Coverage Position Criteria framework often conditions coverage not just on clinical criteria, but on pre-service authorization—and for Category III codes specifically, the authorization process frequently requires clinical documentation that explicitly addresses why the procedure is not experimental for the specific patient.

If your practice currently bills any Category III codes to CIGNA without a prior authorization workflow, that should be your first area of review. The modification to MM_0558 may expand, narrow, or restructure which codes require prior auth—and submitting a claim for a newly auth-required code without obtaining authorization first is one of the cleanest paths to a denied claim that can't be appealed on clinical grounds alone.

What Your Billing Team Should Do